Online inquiry

IVTScrip™ mRNA-Human ARRDC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23280MR)

This product GTTS-WK23280MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARRDC3 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001329670.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 57561
UniProt ID Q96B67
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRDC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23280MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK7364MR IVTScrip™ mRNA-Human ACTL8, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ACTL8
GTTS-WK25674MR IVTScrip™ mRNA-Human ARPP21, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARPP21
GTTS-WK21723MR IVTScrip™ mRNA-Human ARID2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARID2
GTTS-WK14005MR IVTScrip™ mRNA-Human ADAMTS6, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADAMTS6
GTTS-WK25940MR IVTScrip™ mRNA-Human ARL3, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL3
GTTS-WK23279MR IVTScrip™ mRNA-Human ARRDC2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARRDC2
GTTS-WK18517MR IVTScrip™ mRNA-Human ANKRD31, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD31
GTTS-WK11644MR IVTScrip™ mRNA-Human ADGRG6, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADGRG6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW